Safety and Effectiveness of the UV-X System for Corneal Collagen Cross-Linking in Eyes With Progressive Keratoconus
Phase of Trial: Phase III
Latest Information Update: 06 Jul 2017
Price : $35 *
At a glance
- Drugs Riboflavin (Primary)
- Indications Keratoconus
- Focus Therapeutic Use
- Sponsors Avedro
- 19 Jul 2016 According to an Avedro media release, the US FDA has approved Photrexa Viscous, Photrexa and KXL system used in corneal collagen cross-linking for the treatment of corneal ectasia following refractive surgery based on data from this and two other phase III trials.
- 06 Jul 2016 The study design has changed from cross-over assignment to parallel assignment.
- 12 Jun 2014 New trial record